Drug Class
JAK2 inhibitor
Type
brand
Active Ingredient
fedratinib
📋Overview
Inrebic is a medication used in the management of certain blood disorders, particularly myelofibrosis, which is a type of bone marrow cancer. It works by inhibiting specific enzymes involved in the abnormal growth of blood cells. Inrebic is associated with conditions where the bone marrow is replaced by fibrous tissue, leading to symptoms like anemia and an enlarged spleen. Its use is focused on helping to control disease-related symptoms and complications.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Inrebic
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.